OMNICELL, INC. — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2021-03-02

Reporting Person: MELLON CHRISTINE MARIE (EVP, Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-02	Common Stock	A	7872	—	Acquired	7872	Direct
2021-03-02	Common Stock	A	6595	—	Acquired	14467	Direct

Footnotes

F1: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years.

F2: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2022 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance-based stock awards that vest may be 0%, 50% or 100% or 150% Or 200% of the numbers reflected above, depending upon the Company's performance.